文献速递心血管MR

糖原贮积病III型:心脏MRI在检测隐匿性进展中的关键作用

Glycogen Storage Disease Type III: The Critical Role of Cardiac MRI in Detecting Insidious Progression.
PubMed 文献 · Radiol Cardiothorac Imaging · 2025-01-01

本病例报告展示心脏MRI在评估糖原贮积病III型患者心肌受累中的作用,通过2年随访观察心肌改变的进展,并发现两个新的AGL基因杂合突变,扩展了中国GSDIII患者已知AGL突变谱。

要点

  • 心脏MRI可评估GSDIII患者心肌受累并显示2年随访期间心肌改变的进展
  • GSDIII心脏受累虽罕见,但可导致心肌病和心律失常等严重并发症
  • 该病例发现两个新的AGL基因杂合突变,扩展了中国患者AGL突变谱

核心结论

  • 心脏MRI在评估GSDIII患者心肌受累及监测心肌改变进展中具有关键作用,本例发现两个新的AGL基因杂合突变。

研究设计与样本

  • 病例报告,展示一例GSDIII患者的心脏MRI评估及2年随访,并进行AGL基因突变分析。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Glycogen storage disease type III (GSDIII) is a metabolic disorder characterized by glycogen accumulation in tissues, such as the liver, skeletal muscle, and myocardium. While cardiac involvement is rare, it can result in serious complications including cardiomyopathy and arrhythmias. The cardiac manifestations of GSDIII have been scarcely reported. This case demonstrates the role of cardiac MRI in evaluating myocardial involvement in a patient with GSDIII, highlights the progression of myocardial changes over a 2-year follow-up period, and finds two novel heterozygous AGL mutations, expanding the spectrum of known AGL mutation in Chinese patients with GSDIII. Keywords: Cardiac, MR-Imaging, Myocardium Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Ma S, Xu J, Hu H, et al. Glycogen Storage Disease Type III: The Critical Role of Cardiac MRI in Detecting Insidious Progression. Radiol Cardiothorac Imaging. 2025. PMID: 40996332. doi:10.1148/ryct.250025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。